Details for New Drug Application (NDA): 061580
✉ Email this page to a colleague
NDA 061580 describes BACI-RX, which is a drug marketed by X Gen Pharms and is included in one NDA. Additional details are available on the BACI-RX profile page.
The generic ingredient in BACI-RX is bacitracin. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the bacitracin profile page.
The generic ingredient in BACI-RX is bacitracin. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the bacitracin profile page.
Summary for 061580
| Tradename: | BACI-RX |
| Applicant: | X Gen Pharms |
| Ingredient: | bacitracin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 061580
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;FOR RX COMPOUNDING | Strength | 5,000,000 UNITS/BOT | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
